Total Payments
$5,191
2024 Payments
$1,150
Companies
39
Transactions
405
Medicare Patients
1,282
Medicare Billing
$132,990
Payment Breakdown by Category
Food & Beverage$5,130 (98.8%)
Education$61.50 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,130 | 404 | 98.8% |
| Education | $61.50 | 1 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,156 | 168 | $0 (2024) |
| SK Life Science, Inc. | $570.61 | 49 | $0 (2024) |
| Lilly USA, LLC | $402.80 | 22 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $295.14 | 26 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $272.16 | 18 | $0 (2024) |
| Ceribell, Inc. | $268.71 | 1 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $233.00 | 11 | $0 (2023) |
| MDD US Operations, LLC | $221.81 | 29 | $0 (2024) |
| UCB, Inc. | $208.90 | 4 | $0 (2023) |
| Biogen, Inc. | $174.33 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,150 | 109 | ABBVIE INC. ($408.36) |
| 2023 | $1,483 | 140 | ABBVIE INC. ($470.94) |
| 2022 | $1,952 | 142 | Biohaven Pharmaceutical Holding Company Ltd. ($295.14) |
| 2021 | $462.40 | 11 | Ceribell, Inc. ($268.71) |
| 2018 | $112.35 | 1 | Sunovion Pharmaceuticals Inc. ($112.35) |
| 2017 | $31.81 | 2 | Allergan Inc. ($31.81) |
All Payment Transactions
405 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $28.94 | General |
| Category: Neuropsychiatry | ||||||
| 12/18/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/17/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.26 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $4.97 | General |
| Category: Neuropsychiatry | ||||||
| 11/26/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $4.32 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.14 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: PAIN | ||||||
| 11/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $7.42 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Neurology | ||||||
| 10/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $4.45 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $2.18 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: Neuroscience | ||||||
| 10/03/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $6.59 | General |
| Category: Neuropsychiatry | ||||||
| 10/02/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: Neurology | ||||||
| 10/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $2.81 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $5.16 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $37.52 | General |
| Category: Neuropsychiatry | ||||||
| 09/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $5.89 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Neuroscience | ||||||
| 09/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.55 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | PFIZER INC. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 628 | 732 | $253,563 | $66,727 |
| 2022 | 10 | 639 | 750 | $243,109 | $65,585 |
| 2021 | 1 | 15 | 15 | $2,370 | $677.70 |
Total Patients
1,282
Total Services
1,497
Medicare Billing
$132,990
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 72 | 133 | $75,810 | $20,373 | 26.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 78 | 78 | $47,268 | $12,017 | 25.4% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 220 | 232 | $36,656 | $9,883 | 27.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 85 | 111 | $35,187 | $9,692 | 27.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 31 | 32 | $19,200 | $4,276 | 22.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 33 | 35 | $14,875 | $3,974 | 26.7% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 63 | 64 | $10,176 | $2,690 | 26.4% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2023 | 27 | 27 | $10,071 | $2,631 | 26.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 20 | $4,320 | $1,192 | 27.6% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2022 | 50 | 113 | $64,410 | $17,177 | 26.7% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 282 | 301 | $47,558 | $13,219 | 27.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 61 | 61 | $36,966 | $8,975 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 54 | 72 | $22,824 | $6,678 | 29.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 40 | 47 | $19,975 | $6,233 | 31.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 35 | 36 | $21,600 | $5,394 | 25.0% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2022 | 30 | 31 | $11,563 | $3,053 | 26.4% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 52 | 52 | $8,268 | $2,316 | 28.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 19 | 21 | $6,489 | $1,660 | 25.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 16 | 16 | $3,456 | $880.16 | 25.5% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2021 | 15 | 15 | $2,370 | $677.70 | 28.6% |
About Dr. Mohamad Rahwan, M.D
Dr. Mohamad Rahwan, M.D is a Neurology healthcare provider based in West Chester, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2015. The National Provider Identifier (NPI) number assigned to this provider is 1295115822.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohamad Rahwan, M.D has received a total of $5,191 in payments from pharmaceutical and medical device companies, with $1,150 received in 2024. These payments were reported across 405 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($5,130).
As a Medicare-enrolled provider, Rahwan has provided services to 1,282 Medicare beneficiaries, totaling 1,497 services with total Medicare billing of $132,990. Data is available for 3 years (2021–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology, Epilepsy
- Location West Chester, OH
- Active Since 06/09/2015
- Last Updated 08/20/2024
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1295115822
Products in Payments
- QULIPTA (Drug) $615.91
- UBRELVY (Drug) $480.47
- NURTEC ODT (Drug) $426.85
- Ceribell Rapid Response EEG (Device) $268.71
- INGREZZA (Drug) $204.95
- APTIOM (Drug) $185.25
- GOCOVRI (Drug) $165.14
- Nayzilam (Drug) $159.24
- AUSTEDO (Drug) $155.10
- EMGALITY (Drug) $149.50
- XCOPRI (Drug) $148.35
- AMYVID (Drug) $141.00
- KESIMPTA (Drug) $125.27
- XARELTO (Drug) $112.08
- VUMERITY (Drug) $83.13
- Gocovri (Drug) $80.53
- UPLIZNA (Drug) $79.23
- Aimovig (Biological) $72.96
- Ongentys (Drug) $67.21
- Fycompa (Drug) $61.29
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in West Chester
Dr. Mark Callow, Md, MD
Neurology — Payments: $62,306
Neurology $62,306
Joyce Liporace, Md, MD
Neurology — Payments: $34,530
Neurology $34,530
Etsegenet Tizazu, Md, MD
Neurology — Payments: $15,354
Neurology $15,354
Dr. Fred Weinblatt, Md, MD
Neurology — Payments: $14,662
Neurology $14,662
Dr. Mark Macnealy, Do, Jd, DO, JD
Neurology — Payments: $7,323
Neurology $7,323
Carl Waldman, Md, MD
Neurology — Payments: $3,011
Neurology $3,011